Unique ID issued by UMIN | UMIN000016617 |
---|---|
Receipt number | R000019292 |
Scientific Title | Randomized, open-label, phase three study comparing flutamide and abiraterone in patients with advanced prostate cancer after failure of first combined androgen blockade therapy. |
Date of disclosure of the study information | 2015/02/25 |
Last modified on | 2017/07/17 11:09:11 |
Randomized, open-label, phase three study comparing flutamide and abiraterone in patients with advanced prostate cancer after failure of first combined androgen blockade therapy.
Randomized, open-label, phase three study comparing flutamide and abiraterone in patients with advanced prostate cancer after failure of first combined androgen blockade therapy.
Randomized, open-label, phase three study comparing flutamide and abiraterone in patients with advanced prostate cancer after failure of first combined androgen blockade therapy.
Randomized, open-label, phase three study comparing flutamide and abiraterone in patients with advanced prostate cancer after failure of first combined androgen blockade therapy.
Japan |
prostate cancer
Urology |
Malignancy
NO
To compare treatment with flutamide and abiraterone in patients with advanced prostate cancer after failure of first combined androgen blockade therapy.
Safety,Efficacy
Biochemical-free Survival rate
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Patients assigned to receive flutamide therapy.
Patients assigned to receive abiraterone therapy.
40 | years-old | <= |
85 | years-old | >= |
Male
Advanced prostate cancer patients after failure of first combined androgen blockade therapy. Eastern Cooperative Oncology Group performance status of 0 to 2.
Patients who have other active cancer, infection diseases or glaucome are excluded.
40
1st name | |
Middle name | |
Last name | Noriyasu Kawai |
Nagoya City University Graduate School of Medical Sciences
Department of Nephro-urology
1, Kawasumi,Mizuho-cho, Mizuho-ku, Nagoya, Japan
052-853-8266
n-kawai@med.nagoya-cu.ac.jp
1st name | |
Middle name | |
Last name | Ryosuke Ando |
Nagoya City University Graduate School of Medical Sciences
Department of Nephro-urology
1, Kawasumi,Mizuho-cho, Mizuho-ku, Nagoya, Japan
052-853-8266
ryo@med.nagoya-cu.ac.jp
Nagoya City University Graduate School of Medical Sciences
Nagoya City University Hospital
Self funding
NO
2015 | Year | 02 | Month | 25 | Day |
Unpublished
Enrolling by invitation
2015 | Year | 02 | Month | 09 | Day |
2015 | Year | 02 | Month | 26 | Day |
2015 | Year | 02 | Month | 24 | Day |
2017 | Year | 07 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019292
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |